ESTER Biotech GmbH

Germany

ESTER Biotech is a Spin-Off of Leipzig University and its idea was born in the Biocity of Leipzig in 2022. We believe that enzymatic recycling will fundamentally change plastic waste management. By breaking down plastics at a molecular level, enzymes enable a truly circular economy. They ...

Chemeleon

USA

Chemeleon has created a novel platform technology for rapid, accurate, and affordable diagnostics that are capable of detecting a broad range of analytes including drugs, proteins, and viruses. This proprietary, sample-to-answer format provides a colorimetric readout in minutes, visible to the ...

Isomorphic Labs

United Kingdom

Isomorphic Labs was founded in 2021, with a mission to transform drug discovery with the power of artificial intelligence, ushering in a new era of biomedical breakthroughs. Isomorphic Labs is led by AI pioneer Sir Demis Hassabis, and its founding was built on the Nobel-winning AI breakthrough, ...

New Method for Detecting Nanoplastics in Body Fluids

TU Graz and start-up BRAVE Analytics have developed a method for detecting nanoplastics in liquids and determining their composition

16-Apr-2025 - Microplastics and the much smaller nanoplastics enter the human body in various ways, for example through food or the air we breathe. A large proportion is excreted, but a certain amount remains in organs, blood and other body fluids. In the FFG bridge project Nano-VISION, which was launched two ...

From pea to active pharmaceutical ingredient: OrbiFarm revolutionizes global food and drug production

New Veganz Group subsidiary with 40 million valuation - investor entry expected in Q2/2025

16-Apr-2025 - Veganz Group AG founded OrbiFarm GmbH on April 10, 2025 in order to leverage hidden reserves within the company. The purpose of the company is the research, development, patenting, production, distribution and licensing of indoor farming technologies. The focus is on the cultivation of protein ...

Chemeleon to Collaborate with Mayo Clinic to Finalize Ultra-Rapid Assay, Launches $10M Series A

Results in seconds rather than hours: Groundbreaking instrument-free assay nears completion

14-Apr-2025 - Chemeleon, a disruptive innovator in diagnostic technology, announced a collaboration with Mayo Clinic to complete development and clinical validation of their ultra-rapid, instrument-free assay poised to redefine point-of-care (POC) testing in emergency settings. This collaboration will focus on ...

Scopis GmbH

BioVersys